Correspondence 0001493152-23-044461 from MANGOCEUTICALS, INC. (MGRX)
MANGOCEUTICALS, INC.
Date: Dec. 11, 2023 · CIK: 0001938046 · Accession: 0001493152-23-044461
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275993
Letter
Re:
December 11, 2023
VIA EDGAR
Division of Corporation Finance
U.S. Securities & Exchange Commission
F Street, NE
Washington, DC 20549
Attn: Office of Industrial Applications and Services
Mangoceuticals, Inc.
Registration Statement on Form S-1
File No. 333-275993
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for themselves and the other underwriters, hereby join in the request of Mangoceuticals, Inc. that the effective date of the above-referenced registration statement be accelerated so as to permit it to become effective at 4:30 p.m., Eastern time, on Thursday, December 14, 2023, or as soon thereafter as practicable.
Pursuant to 460 under the Act, we wish to advise you that the underwriters have distributed as many copies of the preliminary prospectus dated December 11, 2023 to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of such preliminary prospectus.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Signature page follows]
Very
truly yours,
Boustead Securities, LLC
Show Raw Text
CORRESP
1
filename1.htm
December
11, 2023
VIA
EDGAR
Division
of Corporation Finance
U.S.
Securities & Exchange Commission
100
F Street, NE
Washington,
DC 20549
Attn:
Office of Industrial Applications and Services
Re:
Mangoceuticals,
Inc.
Registration
Statement on Form S-1
File
No. 333-275993
Ladies
and Gentlemen:
Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned,
for themselves and the other underwriters, hereby join in the request of Mangoceuticals, Inc. that the effective date of the above-referenced
registration statement be accelerated so as to permit it to become effective at 4:30 p.m., Eastern time, on Thursday, December 14, 2023,
or as soon thereafter as practicable.
Pursuant
to 460 under the Act, we wish to advise you that the underwriters have distributed as many copies of the preliminary prospectus dated
December 11, 2023 to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of such
preliminary prospectus.
The
undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange
Act of 1934, as amended.
[Signature
page follows]
Very
truly yours,
Boustead Securities, LLC
By:
/s/
Keith Moore
Name:
Keith
Moore
Title:
Chief
Executive Officer
As representative of the underwriters